FDA-Approved Drugs Inhibit MERS-CoV Replication: Screening I
2026-06-07
This study systematically screened 348 FDA-approved compounds and identified four small molecules—chloroquine, chlorpromazine, loperamide, and lopinavir—that inhibit Middle East respiratory syndrome coronavirus (MERS-CoV) replication in cell culture. The findings highlight rapid repurposing potential for anticoronavirus therapies and inform future translational research.
EZH2 Inhibition and 5-Azacytidine Synergize in PTEN-Deficien
2026-06-06
This paper reveals that PTEN-deficient glioblastoma sustains an immunosuppressive microenvironment by suppressing the ERV-MAVS-IFN pathway. Dual targeting with EZH2 inhibition and 5-Azacytidine reactivates viral mimicry and type I interferon signaling, offering a promising strategy to enhance antitumor immunity in this resistant cancer subtype.
Fucoidan (C4038): Sulfated α-L-Fucan for Anticancer Research
2026-06-05
Fucoidan is a highly purified sulfated α-L-fucan derived from brown seaweed, exhibiting robust anticancer and immune-modulating activity. APExBIO's Fucoidan (C4038) demonstrates apoptosis induction in prostate and breast cancer models and suppresses angiogenesis, supported by multiple in vitro and in vivo studies. Its standardized purity and validated mechanisms make it a benchmark tool for oncology and immunology workflows.
Syringin Enhances Sunitinib Response in RCC via EGFR/PI3K/Ak
2026-06-05
This study identifies Syringin as a promising natural product that inhibits renal cell carcinoma (RCC) growth and sensitizes cells to sunitinib by targeting the EGFR/PI3K/Akt pathway. The findings highlight Syringin’s mechanistic role in overcoming drug resistance and provide an evidence-driven rationale for integrating natural products into RCC therapeutic research.
Cycloheximide: Protein Biosynthesis Inhibitor for Cell Resea
2026-06-04
Cycloheximide enables precise, rapid inhibition of protein synthesis, making it a gold-standard tool for dissecting apoptosis, protein turnover, and neuroprotection in cell and animal models. This guide delivers actionable workflows, troubleshooting strategies, and protocol enhancements to maximize data quality and reproducibility in advanced research.
NF 449: Purinergic Receptor Antagonist Accelerates Platelet
2026-06-04
NF 449 stands out as a highly selective purinergic receptor antagonist, redefining platelet aggregation and antithrombotic research with unrivaled potency at the P2X1 ion channel. Discover how its application streamlines experimental workflows, enhances assay precision, and offers actionable troubleshooting insights for demanding platelet activation studies.
Romidepsin (FK228): Epigenetic Mechanisms and Advanced Oncol
2026-06-03
Explore the scientific basis and research protocols for Romidepsin (FK228), a selective HDAC inhibitor pivotal in epigenetic modulation and cancer therapy research. This article delivers a deeper mechanistic analysis and practical guidance distinct from standard protocols.
Protease Inhibitor Cocktail (EDTA-Free, 200X): Mechanisms &
2026-06-03
The Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) from APExBIO is a broad-spectrum protein extraction protease inhibitor designed to stabilize cellular proteins during workflows such as Western blotting and co-immunoprecipitation. Its EDTA-free formulation maintains compatibility with kinase and phosphorylation assays, delivering robust protein degradation prevention for up to 48 hours in culture. This article details its mechanism, evidence base, and best-practice integration.
Discovery of ATG9A and PTOV1 as 14-3-3 Partners in Cancer Re
2026-06-02
This study identifies ATG9A and PTOV1 as novel binding partners for 14-3-3 proteins, elucidating new mechanisms by which autophagy and oncogenic signaling are regulated in cancer cells. These findings advance our understanding of basal autophagy and PTOV1-driven tumor progression, providing new molecular targets for cancer research.
Uridine, Trisodium Salt: Precision Control in RNA-Mediated T
2026-06-02
Discover how Uridine, Trisodium Salt enables precise and scalable RNA-mediated transgene insertion as a nucleoside analog. This article reveals new mechanistic insights and practical assay considerations not covered in existing literature.
Protease Inhibitor Cocktail: Precision in Protein Extraction
2026-06-01
The Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) from APExBIO empowers researchers to preserve protein integrity across sensitive workflows, especially those demanding cation compatibility such as phosphorylation analysis and exosome studies. This article details advanced experimental protocols, troubleshooting strategies, and practical insights for maximizing reproducibility in protein extraction and downstream assays.
5-Methyl-CTP: Advancing mRNA Stability for Translational Suc
2026-06-01
Explore how 5-Methyl-CTP, a 5-methyl modified cytidine triphosphate, is revolutionizing mRNA synthesis by enhancing stability and translation efficiency. This thought-leadership article blends mechanistic insights, emerging clinical evidence, and actionable protocol guidance to empower translational researchers working at the intersection of gene expression studies and next-generation mRNA therapeutics.
SD 169 (indole-5-carboxamide): Reliable p38 MAPK Pathway Con
2026-05-31
This article addresses persistent challenges in cell viability and pathway modulation assays, focusing on how SD 169 (indole-5-carboxamide) (SKU C5850) offers data-driven solutions for robust experimental design. We explore real-world laboratory scenarios, compare vendor options, and provide evidence-backed protocol guidance for researchers prioritizing reproducibility and workflow efficiency.
BX795: Mechanistic Gateway to Translational Cancer Innovatio
2026-05-30
This thought-leadership article explores the mechanistic and strategic value of BX795, a potent PDK1 inhibitor, for translational oncology and innate immunity research. It bridges in vitro assay optimization, competitive landscape analysis, and actionable guidance, with evidence-backed insights and critical protocol parameters. Drawing upon the latest literature and practical scenarios, it provides a roadmap for researchers seeking to harness BX795 for reproducible and clinically relevant discoveries.
Wnt and BMP Pathways Shape Neuroectoderm in Ptychodera flava
2026-05-29
This study elucidates how Wnt and BMP signaling gradients collaboratively pattern the anterior neuroectoderm (ANE) during gastrulation in the indirect-developing hemichordate Ptychodera flava. The findings reveal conserved and divergent roles for these pathways among deuterostomes, deepening our understanding of early neural development and body axis formation.
459 records 16/31 page Previous Next First page 上5页 1617181920 下5页 Last page